Ubiquitination was originally characterized as a signal for protein destruction by the proteasome (1) . However, recent developments have implicated ubiquitin in control of a multitude of cellular processes including signal transduction, apoptosis, DNA repair, protein-protein interaction, endocytosis, and protein trafficking (2) (3) (4) . A host of proteins have been identified that can modify the ubiquitination process, bind ubiquitinated proteins, and deubiquitinate proteins. It has become apparent that the nature of the linkage in polyubiquitin chains dictates function, with Lys 48 -linked chains signaling proteasomal destruction and Lys 63 -linked chains controlling DNA repair and endocytic processes (5) . Given the importance of the ubiquitination system, it is not surprising that viruses have developed methods to exploit it.
The cellular ubiquitination machinery consists of a catalytic cascade of three classes of enzyme acting in concert to transfer the small protein ubiquitin onto target proteins. The first enzyme (E1) 1 is termed a ubiquitin-activating enzyme and forms a thiol-ester bond between its active site cysteine and the carboxyl terminus of ubiquitin in an ATP-dependent reaction. The ubiquitin is then transferred to the cysteine residue of a ubiquitin-conjugating enzyme (E2). Finally, the E3 ubiquitinprotein ligase, which possesses a substrate recognition module, acts to bridge E2 and the target, allowing formation of isopeptide bonds between target lysine ⑀-amino groups and ubiquitin molecules. This modification can lead to monoubiquitination or the creation of polyubiquitin chains on the substrate.
Ubiquitin-protein ligases possess one of three possible E2-interacting domains. The HECT domain is an enzymatically active domain, forming an E3-Ub covalent intermediate before transfer to substrate (6) . RING (7) (8) (9) and U box (10) domains are nonenzymatic and act as bridging proteins that bind to E2s. In addition to these domains, E3s possess a large variety of adaptor domains and motifs to allow binding to target proteins and accessory factors. The RING domain is a small (8 kDa), compact, and stable zinc-binding module. Two zinc ions are bound by a set of eight metal-ligating cysteine and histidine residues in what has been termed a "cross-brace" motif (11, 12) (Fig. 1C) . These residues have a characteristic spacing (Fig. 1 , A and B) and are subclassified into RING-HC (C3HC4) and RING-H2 (C3H2C3) domains dependent on whether the fifth metal ligand is a cysteine or histidine, respectively. In addition to the residue spacing, RING domains possess two highly conserved hydrophobic residues, one immediately N-terminal to metal ligand 5 and the other C-terminal to ligand 6, that form part of the hydrophobic core of the structure (Fig. 1, A and B ).
An interesting development in the field of ubiquitination came with the investigation of two viral systems: murine ␥-herpesvirus 68 and Kaposi's sarcoma-associated herpesvirus * This work was funded by grants from the Wellcome Trust and the United Kingdom Medical Research Council. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The 1 The abbreviations used are: E1, ubiquitin-activating enzyme; E2, ubiquitin carrier protein; E3, ubiquitin-protein isopeptide ligase; HECT, homologous to the E6-AP carboxyl terminus; KSHV, Kaposi's sarcomaassociated herpesvirus, also termed human herpesvirus 8; MHC, major histocompatibility complex; ESCRT-I, endosomal sorting complex required for transport; MARCH, membrane-associated RING-CH; PHD, plant homeodomain; Ub, ubiquitin; Ubc, ubiquitin-conjugating enzyme (H suffix indicates human enzyme); NOE, nuclear Overhauser effect; NOESY, nuclear Overhauser effect spectroscopy; TOCSY, total correlation spectroscopy; DQF-COSY, double-quantum-filtered correlation spectroscopy; HSQC, heteronuclear single-quantum coherence; NTA, nitrilotriacetic acid; MOPS, 4-morpholinepropanesulfonic acid; r.m.s., root mean square.
(KSHV). KSHV is a human herpesvirus and is implicated in the development of Kaposi's sarcoma in individuals afflicted by AIDS (13, 14) . Normally, MHC class I molecules present viral peptide antigens to cytotoxic T cells allowing recognition and destruction of infected cells. However, both murine ␥-herpesvirus 68 and KSHV have developed an immune evasion strategy involving removal of cell surface MHC class I. This evasion is dependent on the expression of viral immediate early proteins: MK3 in the case of murine ␥-herpesvirus 68 (15) and K3 and K5 for KSHV (16) (also referred to as MIR1 and -2, respectively). These proteins share a highly conserved N-terminal domain (MK3/K3, 40% identity; and K3/K5, 64% identity), two transmembrane domains, and a far less well conserved C-terminal region. Genes encoding homologous proteins have also been identified in other ␥-herpesviruses, some poxviruses, and humans (17, 18) .
Experiments have demonstrated that MK3, K3, and K5 possess ubiquitin-protein ligase activity. All are able to catalyze the transfer of multiple ubiquitin molecules to MHC class I molecules in model systems. In the case of MK3, class I molecules are ubiquitinated on the endoplasmic reticulum membrane and destroyed by the proteasome (19) . In contrast, K3 promotes ubiquitination in a post-endoplasmic reticulum compartment, leading to endocytosis of cell surface class I (20 -22) . Endocytosed class I molecules are then routed to the lysosome for destruction in a process dependent on Tsg101, a component of the mammalian ESCRT-I endosomal sorting complex (21) . Nine human, cellular homologs of K3, termed MARCH proteins, have been identified, and two (MARCH-IV and MARCH-IX) have a ubiquitin ligase activity similarly targeted against MHC class I (18).
The domain at the N terminus of these proteins was initially identified as a plant homeodomain (PHD). This domain binds two zinc ions in an interleaved fashion similar to that employed by RING domains (23) . PHD and RING domains differ most obviously in the order of the metal ligands, with the middle two ligands swapped to give a C4HC3 arrangement in the PHD domain. However, recent reports have disputed the classification of these proteins' domains as PHD domains based only on the nature of the metal ligands (24 -27) . The domains lack a crucial tryptophan residue, 2 residues N-terminal to the seventh metal ligand, which is absolutely conserved in all PHD domains (Fig. 1, A and B) . In PHD domains, this residue is involved in making contacts within the hydrophobic core, whereas in RING domains it is solvent exposed. This results in a substantial structural difference between PHD and RING domains in the region between the sixth and seventh metal ligands. In most RING domains of known structure, this stretch forms a helical segment containing a hydrophobic residue involved in E2 binding. In PHD domains, the chain diverges significantly from the path taken in all RING domains of known structure and approaches the second zinc-binding site from the opposite direction. Most PHD domains possess proline residues in this region, which are known to disrupt helix formation. Two recent reports have applied more rigorous techniques using hidden Markov models (24) and analysis of conserved structural features (27) to lend credence to the reclassification of the viral domains as variants of the classic RING domain. These variant domains are found within proteins from a wide variety of eukaryotic organisms including yeast, plants, Caenorhabditis elegans, and mammals. The question of classification extends beyond the issue of nomenclature. The suggestion that PHD domains in general could function as ubiquitin ligases would have huge implications, since many PHD-containing proteins are chromatin-associated and involved in genome maintenance and control.
In this study, the solution structure of the N-terminal domain of the KSHV K3 protein has been determined. This unambiguously confirms its identification as a variant member of the RING domain family, resembling classic RINGs in many important respects. A yeast two-hybrid assay has been used to establish to which E2 ubiquitin-conjugating enzymes the K3 RING can bind and these findings have been confirmed in vitro. Using 15 N-labeled protein, the E2-binding surface on the RING has been mapped by NMR chemical shift perturbations to a region equivalent to that on classic RING domains.
EXPERIMENTAL PROCEDURES
Protein Preparation-The RING region of the KSHV K3 gene, corresponding to residues 1-60, was cloned into a modified pRSET(A) plasmid (Invitrogen) containing a lipoyl domain fusion tag and expressed by the E. coli strain C41(DE3) at 20°C. For isotope labeling, K-MOPS minimal medium (28) containing 15 N-labeled NH 4 Cl and/or 13 C-labeled glucose was used. Full-length sequences encoding UbcH5A to -C (UBE2D1 to -3) were cloned into the pETM-12 vector (EMBL), and
FIG. 1. Sequence alignments and topological features of RING and PHD domains.
A, amino acid sequence alignments of selected RING, PHD, and viral C4HC3-type domains (denoted vRING) and cellular homologs of the K3 RING (MARCH proteins). Zinc site 1 ligands are colored in red, site 2 ligands in dark blue, and diagnostic hydrophobic core residues in green. The conserved tryptophan present in all viral C4HC3 domains and some cellular RING domains is shown in purple. A conserved tryptophan involved in vRING-E2 interaction is highlighted in light blue. In the cellular K3 homologs, an invariant arginine residue replaces this tryptophan residue. B, consensus sequences defining the RING, PHD, and C4HC3 viral RING, colored as in A. X, any residue; ⌽, hydrophobic residues. C, topological diagrams of RING and PHD domains showing cross-brace zinc ligation scheme, conserved secondary structure elements, and altered topology. Metal ligands are colored as in A.
UbcH13 (UBE2N) was cloned into pET-23d (Novagen). E2 proteins were expressed in Rosetta (DE3) pLysS (Novagen) at a temperature of 20°C. All proteins were purified on an Ni 2ϩ -NTA superflow column (Qiagen) pre-equilibrated (50 mM sodium phosphate, 300 mM NaCl, 10 mM imidazole, 10 mM 2-mercaptoethanol, pH 8.0) at 4°C and washed with 50 mM sodium phosphate, 300 mM NaCl, 20 mM imidazole, 10 mM 2-mercaptoethanol, pH 8.0. The proteins were eluted with 300 mM imidazole in this same buffer. Proteins were then dialyzed extensively against phosphate-buffered saline, pH 7.4, and in the case of the ubiquitin-conjugating enzymes immediately purified further on a Superdex 75 column (Amersham Biosciences). RING domain was treated with thrombin following dialysis and run again on Ni 2ϩ -NTA superflow to remove the lipoyl tag before application of the flow-through to a Superdex 75 column. Fractions containing RING were pooled and dialyzed against the appropriate NMR buffers. 1 mM RING domain was dialyzed into a 50 mM potassium phosphate buffer, pH 6.0 (containing 10% D 2 O). 0.3 mM RING-Ubc complexes were dialyzed into a 50 mM potassium phosphate buffer, pH 7.0 (containing 10% D 2 O).
Yeast Two-hybrid Assay-Constructs encoding the first 80 residues of wild-type and W41A K3 (up to the start of the first transmembrane domain) were cloned into the prey vector pACTBD-B by in vivo gap repair cloning as described previously (29) . Full-length open reading frames for all of the ubiquitin-conjugating enzymes screened were cloned by in vivo gap repair into the bait vector pGBAD-B. The bait plasmids encoding the TRP1 marker were transformed by electroporation into the yeast strain PJ69-4A (MATa trp1-901 leu2-3, 112 ura3-52, his3-200 gal4⌬ gal80 LYS2::GAL1-HIS3 GAL2-ADE2 met2::GAL7-lacZ) and tested for self-activation. The prey plasmids encoding the LEU2 marker were transformed into a mating typeswitched, MAT␣ derivative of PJ69 -4A. Yeast containing the prey vectors were mated with MATa yeast containing the bait vectors on YPDA plates for 6 h at 30°C before being replica-plated onto synthetic dropout (SD)ϪTrp/Leu plates to select for diploid yeast and (SD)ϪTrp/ Leu/His and (SD)ϪTrp/Leu/Ade plates to assess the extent of reporter activation. Yeast strains were kindly provided by Dr. Philip James (Department of Biomolecular Chemistry, University of Wisconsin, Madison, WI), whereas bait and prey vectors were provided by Dr. David Markie (Molecular Genetics Laboratory, Pathology Department, Dunedin School of Medicine, Dunedin, New Zealand).
NMR Spectroscopy-The NMR spectra were recorded on Bruker Avance-800, Avance-600, and DMX-500 spectrometers. Two-dimensional NOESY, TOCSY, DQF-COSY, 15 N HSQC, constant time 13 C HSQC, and HNCA HNCO and three-dimensional HNHB, 15 N NOESY, and 15 N TOCSY were recorded at 298 K. The mixing times chosen were 55 ms for TOCSY and 120 ms for NOESY. Spectra were referenced relative to external sodium 2,2-dimethyl-2-silapentane-5-sulfonate for signals of proton and carbon or liquid ammonia for that of nitrogen.
The resonances were assigned using interresidue NOE connectivities by standard procedures (30) . Approximately half the H␤ resonances were assigned stereospecifically using a combination of HNHB and DQF-COSY spectra. All of the Val H␥ and Leu H␦ resonances were stereospecifically assigned using a 10% 13 C-labeled sample of the K3 RING domain (31) .
Structure Determination-The distance constraints derived from the NOESY spectra were classified into four categories corresponding to interproton distance constraints of 1.8 -2.8, 1.8 -3.5, 1.8 -4.75, and 1.8 -6.0 Å, respectively. Hydrogen bonds were identified from an ensemble of structures calculated using only NOE and torsion angle restraints. Protein backbone NH groups whose signals were observed to slowly change with D 2 O at 283 K were assigned to acceptor groups and had hydrogen bonding restraints imposed. Subsequently, the structures were recalculated to check that the hydrogen bonds could be included without increasing the energy of the calculated structures and without altering the overall structure. By applying a simulated annealing protocol (32) implemented in the XPLOR package (33) on 30 random structures with the 1260 experimental constraints, 28 structures were accepted where no distance violation was greater than 0.25 Å and no dihedral angle violation was larger than 5°. All of the spectroscopic characteristics suggested that the N-terminal residues up to Val 6 were unfolded, and hence these residues were excluded from the statistical analysis.
Chemical shift mapping was performed by acquiring 1 H-15 N HSQC spectra from solutions of K3 RING mixed with either UbcH5A or UbcH13 in a 1:1 molar ratio in 50 mM sodium phosphate, 100 mM NaCl, pH 7.4.
Electrostatic Potential Calculations-The program GROMACS (34) was used to create a Protein Data Bank file containing the charge and radius for each atom. This file was used as an input for the potential program from the MEAD suite (35) . MEAD was used to solve the Poisson-Boltzmann equation to generate a three-dimensional map of the electrostatic potential field. Surface potential was visualized by coloring a molecular surface according to values in the MEAD-generated map.
RESULTS

Solution Structure of the K3 N-terminal C4HC3 Domain-
The solution structure of the K3 N-terminal domain was determined by heteronuclear NMR methods using 15 N-labeled protein samples. A summary of the experimentally derived restraints used in structure calculations and the refinement statistics are presented in Table I . Backbone and all atom superpositions of 28 conformers are provided (Fig. 2, A and B) . The structure, including side chains, is mostly very well defined except for a section of 5 residues outside the domain core at the extreme N terminus (root mean square (r.m.s.) deviation of all atoms from their mean positions is 0.88 Å excluding this region). This section has few interactions with the rest of the protein and may as a result be quite disordered. The main chain torsion angles fall primarily within the preferred regions of conformational space (36) .
The overall topology of the fold is as expected with two interleaved zinc binding sites located at opposite sides of the domain, the first composed of three cysteine and one histidine side chains and the second composed completely of cysteines. Only a very limited amount of regular secondary structure is present (Fig. 3A) . This secondary structure consists primarily of a 10-residue ␣-helix between the sixth and seventh metal ligands, although there is also a very small two-strand ␤-sheet toward the N terminus of the domain and a single turn of helix between the fourth and fifth ligands. The remainder of the domain is composed of ordered loops, restrained by the two zinc-binding sites, and a small hydrophobic core.
The two tryptophan residues invariant among the subfamily of viral C4HC3 domains are not buried within the domain core; rather, they are located together on the surface, with the planes of the two side chains perpendicular to one another (Fig.  3A, purple side chains) . This creates a hydrophobic patch on the surface of the molecule that is part of an extended hydrophobic (Fig. 4A ). Adjacent to these tryptophan residues is a small but pronounced hydrophobic pocket. Aside from this nonpolar region, the surface possesses some major charged regions (Fig. 4B ). There is a highly negatively charged region that includes the surface abutting zinc site 1 and forms a shallow groove on the protein surface. This region is contiguous with the five N-terminal disordered residues, four of which are also acidic, negatively charged residues (sequence MEDED). The high negative charge in this section of the surface may allow 
FIG. 4. Surface representations of the K3 RING domain.
A, molecular surface of the domain in the same orientation as Fig. 3 and colored for hydrophobicity. The two tryptophan residues are dark green, and other hydrophobic residues (Tyr, Phe, Ala, Val, Leu, Ile, and Met) are light green. Circled are the surface regions corresponding to the tryptophan residues and a small pocket. B, representation of electrostatic surface potential with positively charged regions in blue and negatively charged regions in red. The right-hand image is rotated 180°a bout the horizontal axis indicated. Highlighted are the acidic region including the surface near to zinc site 1 and the basic patch on the opposite face. Surface potentials were calculated with the program MEAD (35) .
interaction with a basic region elsewhere within the K3 molecule or within target molecules, although the precise mechanism of substrate recognition and ubiquitination is yet to be determined. On the opposite surface of the domain is a positively charged region composed predominantly of four arginine side chains. It is tempting to speculate that this region may interact with the C-terminal region of K3, which contains a high proportion of acidic residues.
Structural Comparison with RING and PHD Domains-In order to determine the closest structural homologs of the K3 N-terminal domain, a search was performed against the Protein Data Bank data base using the EMBL DALI server (37) (available on the World Wide Web at www.ebi.ac.uk/dali/index.html). Three significantly related structures were found, all of which were RING domains: EL5, a RING-H2 protein (r.m.s. deviation of C␣ atoms 3.9 Å, 48 residues aligned), the C4C4 RING NOT4 transcriptional repressor (r.m.s. deviation 2.7 Å, 48 residues aligned), and RAG1 (r.m.s. deviation 3.8 Å, 51 residues aligned). The server found no significant similarity with PHD domains. A direct comparison of the K3 domain with a representative C3HC4 RING (RAG1) and a PHD domain (KAP-1) demonstrates that the K3 domain shares many more features with the C3HC4 RING (Fig. 3, A-C) . The overall tertiary structure of the K3 domain is strikingly similar to that of the RAG1 RING domain, both sharing the ␣-helix conserved within members of the RING domain family. Although the K3 domain lacks the ␤-sheet located between the two zinc-binding sites in C3HC4-type domains (Fig. 3B) , the overall topology of the chain in this region and throughout the core of the domain is very similar. The possession of an ␣-helix in place of this ␤-sheet may be a common feature of the viral domains based on their high sequence similarity. The second tryptophan in the K3 domain is also located at a position within the ␣-helix precisely equivalent to that of a conserved hydrophobic residue in RING domains. The PHD domain of KAP-1 follows a similar path to both the K3 domain and the RAG1 RING up to the sixth metal ligand prior to the RING ␣-helix. However, after this point, the KAP-1 chain diverges significantly (Fig. 3C , red section of chain), with no ␣-helix formed and a different mainchain conformation allowing burial of the additional PHDspecific tryptophan residue (23) . Therefore, these results establish unambiguously that the K3 C4HC3-type domain (and by inference those of the entire related viral and human families) is a variant type of RING domain.
Identification of K3-interacting Ubiquitin-conjugating Enzymes-In order to function as an E3 ubiquitin-protein ligase, a protein must interact with at least one ubiquitin-conjugating enzyme. The KSHV genome itself does not encode any members of the Ubc family, suggesting that K3 exploits a cellular E2 to fulfill its function. In order to determine whether K3 could bind to any E2 proteins, a yeast two-hybrid assay was performed. In the assay, the K3 RING domain was used as bait against a selection of 24 human Ubc proteins. Only four of the possible Ubc proteins were identified as binding partners for K3: the core cellular E2s UbcH5A to -C and UbcH13 (Table II) . Of these, only UbcH13 gave a signal on the more stringent Ade selection. A W41A mutant of the K3 RING, which lacks the conserved tryptophan residue important for c-Cbl interaction with UbcH7 (38) , was also included in the screen. Expression of K3 W41A in a cell culture model of K3 action results in an inactive molecule that, while able to bind MHC class I, is unable to promote ubiquitination (21) . This mutant was found to be incapable of interaction with any of the E2s screened. The C-terminal region of K3 (following the second transmembrane domain) was found not to interact with any E2 enzymes (data not shown).
The four potential binding partners identified by the yeast two-hybrid assay may not necessarily interact in vivo. Within the context of the full-length K3 protein and a membranous environment, there may be a preferential interaction with only one of the four E2s. Another possibility is that an entirely different ubiquitin-conjugating enzyme is employed physiologically.
Mapping of the K3 RING-E2 Interaction Surface-To determine whether the E2 interaction with the K3 RING domain was similar to that with classical RING domains, the interaction surface on the K3 RING was determined by mapping NMR chemical shift perturbations. Residues involved in binding to UbcH13 were mapped upon E2 addition to 15 N-labeled K3 RING domain. Cross-peaks in the 1 H-15 N HSQC spectra for the bound state could be assigned by their proximity to those in the unbound state (Fig. 5A) . Residues with significant chemical shift alterations mostly mapped to a single, contiguous surface on the K3 RING (Fig. 5B) . Preliminary results indicate that UbcH5A also binds to the same surface of the RING domain. This surface mainly overlaps with the hydrophobic patch on the domain described earlier (Fig. 4B ) and mostly consists of residues located about the first zinc-binding site or within the 10-residue ␣-helix. Significantly, both the tryptophan conserved in many cellular C3HC4 RING domains (Trp 41 ) and the tryptophan conserved in the viral C4HC3 RING domains (Trp 10 ) are involved in E2 interaction. A conserved Ile immediately preceding the second metal ligand is also implicated in E2 binding, as is also observed for the binding of UbcH7 to c-Cbl (39) . The binding surface is in the same location as found for C3HC4 RING domains, strongly suggesting that E2 proteins bind to the K3 RING in a comparable manner. 
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variant RING domains, other than the alteration of zinc ligands, is the loss of the small ␤-sheet found in RING domains and the replacement of one strand of this sheet with a single turn of helix. Whether this small architectural difference has any functional significance is unknown.
Aravind et al. (27) have shown that sensitive PSI-BLAST searches with the variant RING domain identify homology to the Saccharomyces cerevisiae protein SSM4, suggesting a divergence from classic RING domains early in eukaryotic evolution. The identification of a family of human proteins related to K3 (18) and the conservation of such proteins throughout eukaryotic evolution suggests that they must have an important functional role. All of the proteins containing the variant RING domain are predicted to contain two or more transmembrane helices, an unusual feature for ubiquitin-protein ligases, further suggesting a vital and unique function. It will be val- uable to discover the non-MHC class I targets of the human MARCH proteins and the importance of MARCH protein activity to the correct functioning of the human cell. The confirmation of the K3 N-terminal domain as a RING domain should help to further the correct classification of other related domains as either RING or PHD. Two further proteins with supposed PHD domains and ubiquitin-protein ligase activity have been identified: the mitogen-activated protein kinase kinase kinase MEKK1 (40) and FANCL (41) (also termed PHF9), a component of the Fanconi anemia complex. Both of these proteins' domains possess a C4HC3-type zinc ligand arrangement, but neither possesses the conserved PHD-specific tryptophan residue. Indeed, PSI-BLAST searches with these two domains retrieve RING domains as opposed to PHD domains. Significantly, this result suggests that true PHD domain-containing proteins are unlikely to function as ubiquitinprotein ligases and must be fulfilling another role. Proteins with genuine PHD domains are in general unlikely to interact with E2s due to the significant differences of these domains at the location equivalent to the E2-RING binding surface. A possible exception to this rule may be the PHD1 domain of the autoimmune regulator protein AIRE, which appears to support ubiquitination in vitro (42) . Further investigation will be required to determine whether this domain is an atypical PHD domain or a distant outlier of the RING family.
Ubiquitin-conjugating Enzyme Interaction-For a protein to function as an E3, an interaction with an E2 enzyme must occur, and the K3 RING domain was found to interact with 4 of a possible 24 E2 enzymes assayed. Interaction with UbcH5A-C and UbcH13 was confirmed in vitro, although this does not preclude interaction with other E2s that were either not included in the assay or gave false negative results. A mutant form of K3 with a conserved tryptophan mutated to alanine (K3 W41A) was unable to interact with any of the E2 enzymes tested.
The binding location for E2s on the K3 RING maps to a surface corresponding to that used by classical C3HC4-type domains. This surface is predominantly hydrophobic in character and includes the tryptophan residue projecting from the ␣-helix that is conserved as a hydrophobic residue in most other RING domains. In the structure of c-Cbl with UbcH7, this residue is observed to form critical contacts with a Phe residue from loop 1 of UbcH7 and a Pro from loop 2 (39) . The K3 RING also possesses a partially conserved Ile residue immediately preceding the second metal ligand, which is also involved in making important hydrophobic contacts. However, the E2-binding surface on all of the viral C4HC3 RING domains has one potentially important discrepancy, an additional tryptophan residue after the first cysteine residue whose side chain is orthogonal to the conserved Trp. This residue significantly alters the surface topography of the binding site, removing a pocket found in many cellular RING domains and creating a novel, small pocket. Such a change in the surface may have a functional significance. It is possible that the altered surface possesses a preference for a certain subset of cellular E2 enzymes with residues complementary to the binding site. The KSHV K5 RING domain possesses identical side chains for 11 of the 15 binding residues (including the two tryptophan residues), suggesting that it too may interact with the same set of E2 enzymes. The conserved tryptophan at position 10 of the K3 RING domain is invariably replaced by a basic lysine or arginine residue in the cellular MARCH homologs (with the exception of MARCH V), suggesting that the viral RING domains possess altered binding affinity or specificity.
The identification of UbcH13 as a potential binding partner of K3 raises an intriguing prospect. This member of the E2 family has a unique facet to its function due to the formation of a heterodimer with Mms2 (UEV2), a noncatalytic ubiquitinconjugating enzyme variant (43, 44) . The Ubc13-Mms2 heterodimer is capable of catalyzing the formation of polyubiquitin chains linked via Lys 63 residues (45) (46) (47) . Such Lys 63 -linked poly-Ub chains were initially characterized as having a DNA repair-based function (48) but have since been shown to additionally function in endocytic processes. Monoubiquitination is often sufficient for endocytosis to occur, but in cases where Lys 63 chains are created, the process is enhanced (49) . This observation suggests that K3 may possibly be catalyzing the formation of Lys 63 -linked chains on MHC class I molecules to enable their efficient removal from the cell surface.
In summary, this viral system has taught us that the RING domain is more variable than once thought, able to accommodate alterations in metal ligand nature and secondary structure. The structure definitively indicates that all similar C4HC3 domains with ubiquitin ligase activity are RING domains as opposed to PHD domains. The C4HC3 RING is clearly capable of supporting E2-dependent ubiquitination, although the physiological E2 partner of K3 remains to be confirmed. A structure of such a domain bound to an E2 enzyme would further rationalize the specificity of E2-E3 interactions. Perhaps the most interesting issues pertaining to the K3 system that remain unanswered are the molecular details of target protein acquisition and ubiquitin transfer, which will require further structural and functional studies.
